*January 2022*
In this video, EGFR Resisters co-founders Jill Feldman and Ivy Elkins gave a presentation about the clinical trial life cycle. It starts at about 1:50.
We are a group of lung cancer patients with EGFR mutations who have developed resistance to at least one targeted treatment drug, or who face probable resistance in the future. Caregivers are also welcome. We are here to share treatment experiences, information about clinical trials, breaking news about research developments, and other information with each other.